logo
Kansas governor, Merck announce $895 million expansion, adding 200 jobs

Kansas governor, Merck announce $895 million expansion, adding 200 jobs

Yahoo08-05-2025

Gov. Laura Kelly, seen here at May 2, 2025, even, announced that Merck Animal Health is expanding its De Soto plant with a $365 million capital initiative. (Sherman Smith/Kansas Reflector)
TOPEKA — Merck Animal Health will build an $895 million capital expansion project and add 200 jobs at its De Soto manufacturing facility, Gov. Laura Kelly and the company announced Thursday.
Merck will invest $860 million in its existing facility and $35 million in its research and development laboratories, a press release said.
Kelly billed the announcement as the second-largest private investment in Kansas history.
'This extraordinary investment by Merck Animal Health underscores my administration's commitment to securing a strong economic future for our state and ensuring prosperity for generations to come,' Kelly said. 'Public-private partnerships that lead to major global projects, such as those with Merck, Fiserv and Panasonic — just to name a few recent successes — are occurring because people believe in Kansas.'
Merck Animal Health has been in the De Soto community for more than 20 years, said Mayor Rick Walker.
'We've watched them grow. They've grown with us. So we're excited to see them continue to make this level of investment in our city,' he said. 'The Merck property, the way their project lays out, it's pretty much all upside on that. It's very little stress on our transportation infrastructure and our utility infrastructure.'
City administrator Mike Brungardt said other economic developments, like the decision by Panasonic to build a 300-acre facility in the city's Astra Enterprise Park, are 'wonderful,' but seeing Merck expand is special in a different way.
'It's a recognition that not only did they come here 20 or 25 years ago, but they made the decision again to redouble their investment in our community,' he said. 'This one when it came across as a possibility, it stood out from the others because this is an existing partner in our community with an existing employment base. They've already invested an enormous amount in the fabric of our community.'
Brungardt added that Lt. Gov. David Toland, who also serves as state commerce secretary, said in a speech Thursday that if the company had decided not to do this expansion, its future plans for the campus were uncertain.
'This was a very big win in ways that the others just weren't,' Brungardt said.
Brungardt said a tax incentive package for the project has not been finalized. Merck Animal Health has been investing in its existing facility for the past five or 10 years, he said, and has received an incentive package.
That package has been an 80% property tax abatement for 10 years, Walker said, adding that there likely will be a construction sales tax exemption.
The 200,000-square-foot manufacturing facility project will expand filling and freeze dryer capacity for large molecule vaccines and biologic products for Merck Animal Health, the press release said.
Site preparation and facility design will start immediately, creating 2,500 construction jobs. Commercial manufacturing is expected to begin in 2030.
'Our De Soto manufacturing facility is strategically located in the heart of the Animal Health Corridor. This region is renowned for its concentration of animal health companies, fostering an unparalleled ecosystem for innovation, collaboration and industry leadership,' said Richard DeLuca, Merck Animal Health president.
The KC Animal Health Corridor is anchored by Manhattan, Kansas, and Columbia, Missouri, and is home to about 300 animal health companies. Those companies represent 56% of total worldwide animal health, diagnostics and pet food sales, the organization's website said.
The corridor supports jobs in this field, Brungardt said. Workforce has been an ongoing topic of discussion.
'Within a 30-minute drive of De Soto, we've got 2 million people living here,' he said. 'Mechanisms to deliver the pipeline for workforce for advanced manufacturing and research and development jobs tie in with the Animal Health Corridor. Manhattan will be a pipeline for the research development jobs.'
Since the 2017 Tax Cuts and Jobs Act, Merck has allocated more than $12 billion to enhance domestic manufacturing and research capabilities, with additional planned investments of more than $9 billion over the next four years, the press release said.
'Merck's massive expansion in De Soto further elevates Kansas' long-established status as a global leader in animal health,' Toland said. 'The opportunities and ripple effects of having almost $1 billion surge into the local economy will have far-reaching and long-lasting reverberations across the entire state.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How the Brooklyn Nets can help the Boston Celtics this NBA offseason
How the Brooklyn Nets can help the Boston Celtics this NBA offseason

Yahoo

time9 minutes ago

  • Yahoo

How the Brooklyn Nets can help the Boston Celtics this NBA offseason

Can the Brooklyn Nets help the Boston Celtics this NBA offseason? As the team in the league with the largest payroll that is also over the second apron long enough to incur the worst penalties mandated by the collective bargaining agreement (CBA), the Celtics are staring at being hit with a potentially historic payroll and tax bill on top of the punitive team building penalties the CBA will dole out on Boston. Enter the Nets, who are the only team in the Association that is going to have the sort of cap space the Celtics would need to absorb the kind of salary necessary in single-team deals to get Boston out of being a second (and perhaps even first) apron ball club. There are other, more complex ways the Celtics could get cheaper -- and others that would take more time -- but if the Celtics want to get cheaper in a hurry, all roads lead to Brooklyn. Advertisement The cohost of the CLNS Media "Garden Report" podcast, Bobby Manning, sat down with the New York Post's Brian Lewis on a recent episode of the show to talk over the potentiality for a Nets-Celtics cap cleansing team up. Take a look at the clip embedded below to hear what they had to say. If you enjoy this pod, check out the "How Bout Them Celtics," "First to the Floor," and the many other New England sports podcasts available on the CLNS Media network: This article originally appeared on Celtics Wire: How the Brooklyn Nets can help the Celtics this NBA offseason

Baird Lowers Tesla (TSLA) to Hold, Citing Valuation and Robotaxi Risk
Baird Lowers Tesla (TSLA) to Hold, Citing Valuation and Robotaxi Risk

Yahoo

time10 minutes ago

  • Yahoo

Baird Lowers Tesla (TSLA) to Hold, Citing Valuation and Robotaxi Risk

Tesla Inc. (NASDAQ:TSLA) is one of the 10 best tech stocks to buy according to billionaires right now. On June 9, Ben Kallo of Robert W. Baird downgraded Tesla from Buy to Hold mainly on valuation concerns, while keeping his price target unchanged at $320. In his view, much of the recent upside in the stock, up over 20% since Q1 earnings, has already factored in the excitement around Tesla's planned robotaxi service and the prospect of a lower-cost electric vehicle. Hadrian / Kallo cited two key areas of concern behind the downgrade. First, he flagged elevated market expectations ahead of Tesla's upcoming robotaxi event, which he believes could be difficult to meet. Second, he raised questions around 'key-man' risk, pointing to ongoing uncertainty tied to CEO Elon Musk's central role in the company's strategic direction. While Musk has resigned from the Department of Government Efficiency (DOGE), it may still take time for him to recoup investor confidence. While Kallo still considers Tesla a core long-term holding, he expressed skepticism about the near-term ramp-up of the robotaxi program, describing current projections as potentially too ambitious. He also noted that Elon Musk's political affiliations, particularly his perceived alignment with former President Trump, could introduce additional headline and regulatory risk moving forward. Tesla Inc. (NASDAQ:TSLA) is an EV manufacturer and clean energy company known for its innovative approach to sustainable transportation and energy solutions. It designs, manufactures, and sells electric vehicles, battery energy storage systems, solar products, and related services. It currently manufactures five different consumer vehicles: the Model 3, Y, S, X, and the Cybertruck. While we acknowledge the potential of TSLA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target.
Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target.

Yahoo

time10 minutes ago

  • Yahoo

Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target.

Centene Corporation (NYSE:CNC) is one of the 8 cheap beginner stocks to buy right now. On June 9, Morgan Stanley analysts began covering Centene Corporation (NYSE:CNC) with an Overweight rating and a $70 price target. The analysts emphasized Centene's status as a prominent managed care provider, particularly within the Medicare Advantage, Medicaid, and Individual Exchange programs. Centene's robust footprint in the Medicaid market is a significant asset, the analysts pointed out, despite the program's difficulties, which include financing instability and state rate-member acuity mismatch. In order to support long-term growth, they also highlighted possible expansion prospects in the ICHRA market and D-SNP integration. Morgan Stanley also highlighted the possibility of ongoing cost reductions along with faster growth in better margin categories, which might eventually result in margin increase. The firm predicts that over the next three years, these elements combined with capital deployment will sustain an EPS compound annual growth rate of 8.8%. Centene Corporation (NYSE:CNC), headquartered in St. Louis, Missouri, is a managed care company that serves as a middleman between government-sponsored and privately insured healthcare programs. While we acknowledge the potential of CNC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store